David Henry Mack - 27 Oct 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Reporting relationship: President and CEO, Director
Issuer ticker: PMVP
Reported as of: 27 Oct 2025
Net transaction value: +$302,281
SEC form: 4
Accepted by SEC: 29 Oct 2025, 16:11:57 UTC
Prior SEC filing: 03 Jul 2025
Next SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Ticktin, by power of attorney

Key filing fact

David Henry Mack filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 29 Oct 2025.

Key facts

This page summarizes David Henry Mack's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Oct 2025, 16:11.

Change

Previous filing in this sequence was filed on 03 Jul 2025.
Current net transaction value: +$302,281.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001341642 Primary reporting owner

Mack David Henry

Relationship: President and CEO, Director
Address: C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON
Signature: /s/ Robert Ticktin, by power of attorney
Signature date: 29 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMVP transaction

Common Stock

Options Exercise

Transaction value: $302,281
Shares: +220,643
Change %: +96%
Price: $1.37
Shares after: 451,109
Date: 27 Oct 2025
Ownership: Direct
Footnotes: F1

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 165,307
Date: 27 Oct 2025
Ownership: See footnote
Footnotes: F2

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 453,582
Date: 27 Oct 2025
Ownership: See footnote
Footnotes: F3, F4

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 56,978
Date: 27 Oct 2025
Ownership: See footnote
Footnotes: F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PMVP transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -220,643
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 27 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 220,643
Exercise price: $1.37
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust (the "Revocable Trust").

Footnote F2

The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Footnote F3

Includes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Revocable Trust.

Footnote F4

The shares are held of record by the Revocable Trust.

Footnote F5

The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Footnote F6

The shares subject to the option are fully vested and immediately exercisable.